AssetMark Inc
NVO

AssetMark Inc’s Novo Nordisk NVO Stock Holding History

AssetMark Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.56M Sell
178,606
-47,182
-21% -$2.03M 0.01% 596
2026
Q1 		$8.3M Sell
225,788
-11,608
-5% -$550K 0.02% 547
2025
Q4 		$12.1M Sell
237,396
-4,528
-2% -$232K 0.02% 448
2025
Q3 		$13.4M Buy
241,924
+24,425
+11% +$1.43M 0.03% 384
2025
Q2 		$15M Sell
217,499
-210,124
-49% -$14.3M 0.04% 328
2025
Q1 		$29.7M Sell
427,623
-21,507
-5% -$1.78M 0.08% 199
2024
Q4 		$38.6M Buy
449,130
+7,248
+2% +$784K 0.1% 158
2024
Q3 		$52.6M Buy
441,882
+21,553
+5% +$2.87M 0.15% 132
2024
Q2 		$60M Buy
420,329
+1,545
+0.4% +$205K 0.19% 106
2024
Q1 		$53.8M Sell
418,784
-11,727
-3% -$1.4M 0.17% 121
2023
Q4 		$44.5M Sell
430,511
-1,734
-0.4% -$171K 0.16% 128
2023
Q3 		$39.3M Sell
432,245
-64,467
-13% -$5.68M 0.16% 139
2023
Q2 		$40.2M Buy
496,712
+28,094
+6% +$2.29M 0.16% 136
2023
Q1 		$37.3M Buy
468,618
+31,322
+7% +$2.22M 0.15% 138
2022
Q4 		$29.6M Sell
437,296
-16,444
-4% -$964K 0.13% 145
2022
Q3 		$22.6M Buy
453,740
+47,984
+12% +$2.57M 0.11% 155
2022
Q2 		$22.6M Buy
405,756
+7,222
+2% +$401K 0.1% 166
2022
Q1 		$22.1M Buy
398,534
+16,838
+4% +$864K 0.09% 176
2021
Q4 		$21.4M Buy
381,696
+35,264
+10% +$1.91M 0.09% 178
2021
Q3 		$16.6M Buy
346,432
+34,698
+11% +$1.68M 0.07% 188
2021
Q2 		$13.1M Sell
311,734
-22
-0% -$853 0.06% 211
2021
Q1 		$10.5M Sell
311,756
-9,626
-3% -$343K 0.05% 212
2020
Q4 		$11.2M Sell
321,382
-8,476
-3% -$293K 0.06% 208
2020
Q3 		$11.5M Buy
329,858
+9,246
+3% +$308K 0.07% 188
2020
Q2 		$10.2M Buy
320,612
+14,378
+5% +$459K 0.07% 185
2020
Q1 		$9.22M Sell
306,234
-16,218
-5% -$483K 0.08% 173
2019
Q4 		$9.33M Buy
322,452
+241,604
+299% +$6.69M 0.07% 206
2019
Q3 		$2.09M Buy
80,848
+60,682
+301% +$1.53M 0.02% 275
2019
Q2 		$515K Buy
20,166
+1,100
+6% +$27.2K ﹤0.01% 350
2019
Q1 		$499K Buy
19,066
+558
+3% +$13.7K ﹤0.01% 344
2018
Q4 		$426K Sell
18,508
-433,850
-96% -$9.64M ﹤0.01% 354
2018
Q3 		$10.7M Buy
452,358
+42,248
+10% +$1.03M 0.1% 167
2018
Q2 		$9.46M Buy
410,110
+50,486
+14% +$1.2M 0.09% 169
2018
Q1 		$8.86M Buy
359,624
+299,982
+503% +$7.88M 0.09% 168
2017
Q4 		$1.6M Buy
59,642
+47,076
+375% +$1.2M 0.02% 268
2017
Q3 		$303K Sell
12,566
-217,876
-95% -$4.92M ﹤0.01% 413
2017
Q2 		$4.94M Buy
230,442
+2,748
+1% +$55.5K 0.06% 187
2017
Q1 		$3.9M Buy
227,694
+3,014
+1% +$52.5K 0.05% 198
2016
Q4 		$4.03M Buy
224,680
+19,292
+9% +$350K 0.06% 179
2016
Q3 		$4.27M Buy
205,388
+67,900
+49% +$1.68M 0.07% 175
2016
Q2 		$3.7M Buy
137,488
+8,460
+7% +$232K 0.06% 173
2016
Q1 		$3.5M Sell
129,028
-60,954
-32% -$1.63M 0.06% 173
2015
Q4 		$5.52M Buy
189,982
+31,210
+20% +$864K 0.1% 144
2015
Q3 		$4.31M Buy
158,772
+113,728
+252% +$3.22M 0.09% 135
2015
Q2 		$1.23M Sell
45,044
-30,954
-41% -$870K 0.03% 269
2015
Q1 		$2.03M Sell
75,998
-6,014
-7% -$138K 0.04% 195
2014
Q4 		$1.74M Sell
82,012
-7,344
-8% -$164K 0.04% 225
2014
Q3 		$2.13M Sell
89,356
-7,092
-7% -$163K 0.05% 185
2014
Q2 		$2.23M Sell
96,448
-56,730
-37% -$1.25M 0.05% 177
2014
Q1 		$3.5M Sell
153,178
-795,222
-84% -$16.9M 0.09% 108
2013
Q4 		$3.5M Buy
948,400
+757,760
+397% +$13.2M 0.08% 115
2013
Q3 		$3.23M Buy
+190,640
New +$3.21M 0.08% 135

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AssetMark Inc's NVO Position: Q2 2026 in Review

AssetMark Inc reduced its Novo Nordisk (NVO) stake by 21% in Q2 2026, selling an estimated $2.03M and leaving 178,606 shares worth $8.56M. The position accounts for 0.01% of the portfolio, ranked #596.

AssetMark Inc first reported a position in NVO in Q3 2013 and has held it in 52 quarters since. The position peaked at $60M in Q2 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • AssetMark Inc held 178,606 shares of Novo Nordisk worth $8.56M as of Q2 2026.
  • AssetMark Inc sold 47,182 Novo Nordisk shares in Q2 2026, an estimated $2.03M.
  • Novo Nordisk made up 0.01% of AssetMark Inc's portfolio in Q2 2026, its #596 holding.
  • AssetMark Inc first reported a position in Novo Nordisk in Q3 2013 and has held it in 52 quarters since.
  • AssetMark Inc's Novo Nordisk position peaked at $60M in Q2 2024.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.